Delivery Order SPE2DB20D3303-SPE2DB25FA3BL
- Not listed
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4561090582 - JADENU 360 MG TABLET 30S. The $130,456.56 contract has a completion date of May 25, 2023 and was awarded on May 24, 2023. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to supply pharmaceuticals and medical supplies to the Defense Logistics Agency. The company has previously received...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,475.44 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency Troop Support Medical awarded a $10,909 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561545426 JADENU 360 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. No additional details were provided regarding the original solicitation or whether this award is associated with a larger governmentwide acquisition contract vehicle. The prime contractor is Amerisourcebergen Drug...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply JADENU 360 MG TABLET 30S. The $147,112.99 delivery order is not associated with a set-aside program and was awarded on August 31, 2022, with a completion date of September 1, 2022. Amerisourcebergen Drug Corp provides pharmaceutical products and services as a prime contractor to U.S. government agencies, primarily...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,062.11 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,680.51, is a delivery order for 4567795570 ! JADENU 360 MG TABLET 30S. It is a firm fixed price contract with an ultimate completion date of April 4, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $42,178.14 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561654541 JADENU 360 MG TABLET 30S to an agency location in Conshohocken, Pennsylvania. Performance is required from July 31 through August 1, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order supports the Defense Logistics Agency's mission to provide...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $21,354.75 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription medications,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,139.12 firm fixed price contract is for the provision of JADENU 360 MG TABLET 30S, a pharmaceutical product. The delivery order has a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous federal contracts from DLA Troop Support Medical to supply...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3BLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $28,000 to AmerisourceBergen Drug Corp for JADENU (fedratinib) 360 mg tablets (30-count supply) on August 28, 2025, with a completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that specializes in supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an approximately $1 billion global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. JADENU is a prescription medication used in the treatment of myelofibrosis, reflecting the contractor's capability to deliver specialized pharmaceutical products across multiple therapeutic domains to support federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.0k | 8/28/25 |